Annual CFF
-$91.00 K
-$1000.00-1.11%
December 31, 2023
Summary
- As of February 25, 2025, TARA annual cash flow from financing activities is -$91.00 thousand, with the most recent change of -$1000.00 (-1.11%) on December 31, 2023.
- During the last 3 years, TARA annual CFF has fallen by -$189.49 million (-100.05%).
- TARA annual CFF is now -100.05% below its all-time high of $189.40 million, reached on December 31, 2020.
Performance
TARA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$42.09 M-100.00%
September 30, 2024
Summary
- As of February 25, 2025, TARA quarterly cash flow from financing activities is $0.00, with the most recent change of -$42.09 million (-100.00%) on September 30, 2024.
- Over the past year, TARA quarterly CFF has increased by +$27.00 thousand (+100.00%).
- TARA quarterly CFF is now -100.00% below its all-time high of $139.83 million, reached on September 30, 2020.
Performance
TARA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$42.02 M
+$27.00 K+0.06%
September 30, 2024
Summary
- As of February 25, 2025, TARA TTM cash flow from financing activities is $42.02 million, with the most recent change of +$27.00 thousand (+0.06%) on September 30, 2024.
- Over the past year, TARA TTM CFF has increased by +$42.11 million (+46271.43%).
- TARA TTM CFF is now -77.82% below its all-time high of $189.40 million, reached on December 31, 2020.
Performance
TARA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TARA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.1% | +100.0% | +10000.0% |
| 3 y3 years | -100.0% | +100.0% | +10000.0% |
| 5 y5 years | -103.0% | +100.0% | +10000.0% |
TARA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.1% | +60.1% | -100.0% | +100.0% | at high | >+9999.0% |
| 5 y | 5-year | -100.0% | +60.1% | -100.0% | +100.0% | -77.8% | >+9999.0% |
| alltime | all time | -100.0% | +60.1% | -100.0% | +100.0% | -77.8% | >+9999.0% |
Protara Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $42.02 M(+0.1%) |
| Jun 2024 | - | $42.09 M(<-9900.0%) | $41.99 M(<-9900.0%) |
| Mar 2024 | - | -$76.00 K(<-9900.0%) | -$103.00 K(+13.2%) |
| Dec 2023 | -$91.00 K(+1.1%) | $0.00(-100.0%) | -$91.00 K(0.0%) |
| Sep 2023 | - | -$27.00 K(<-9900.0%) | -$91.00 K(+11.0%) |
| Jun 2023 | - | $0.00(-100.0%) | -$82.00 K(0.0%) |
| Mar 2023 | - | -$64.00 K(<-9900.0%) | -$82.00 K(-8.9%) |
| Dec 2022 | -$90.00 K | $0.00(-100.0%) | -$90.00 K(0.0%) |
| Sep 2022 | - | -$18.00 K(<-9900.0%) | -$90.00 K(+25.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$72.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$72.00 K(<-9900.0%) | -$72.00 K(-68.4%) |
| Dec 2021 | -$228.00 K(-100.1%) | $0.00(0.0%) | -$228.00 K(-102.2%) |
| Sep 2021 | - | $0.00(0.0%) | $10.49 M(-93.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $150.31 M(+0.2%) |
| Mar 2021 | - | -$228.00 K(-102.1%) | $149.94 M(-20.8%) |
| Dec 2020 | $189.40 M(>+9900.0%) | $10.71 M(-92.3%) | $189.40 M(+6.0%) |
| Sep 2020 | - | $139.83 M(<-9900.0%) | $178.69 M(+359.8%) |
| Jun 2020 | - | -$371.00 K(-100.9%) | $38.86 M(-0.9%) |
| Mar 2020 | - | $39.23 M | $39.23 M |
| Dec 2019 | $500.00 K(-83.2%) | - | - |
| Dec 2018 | $2.98 M | - | - |
FAQ
- What is Protara Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Protara Therapeutics?
- What is Protara Therapeutics annual CFF year-on-year change?
- What is Protara Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Protara Therapeutics?
- What is Protara Therapeutics quarterly CFF year-on-year change?
- What is Protara Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Protara Therapeutics?
- What is Protara Therapeutics TTM CFF year-on-year change?
What is Protara Therapeutics annual cash flow from financing activities?
The current annual CFF of TARA is -$91.00 K
What is the all time high annual CFF for Protara Therapeutics?
Protara Therapeutics all-time high annual cash flow from financing activities is $189.40 M
What is Protara Therapeutics annual CFF year-on-year change?
Over the past year, TARA annual cash flow from financing activities has changed by -$1000.00 (-1.11%)
What is Protara Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of TARA is $0.00
What is the all time high quarterly CFF for Protara Therapeutics?
Protara Therapeutics all-time high quarterly cash flow from financing activities is $139.83 M
What is Protara Therapeutics quarterly CFF year-on-year change?
Over the past year, TARA quarterly cash flow from financing activities has changed by +$27.00 K (+100.00%)
What is Protara Therapeutics TTM cash flow from financing activities?
The current TTM CFF of TARA is $42.02 M
What is the all time high TTM CFF for Protara Therapeutics?
Protara Therapeutics all-time high TTM cash flow from financing activities is $189.40 M
What is Protara Therapeutics TTM CFF year-on-year change?
Over the past year, TARA TTM cash flow from financing activities has changed by +$42.11 M (+46271.43%)